NO20053712L - Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten - Google Patents

Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten

Info

Publication number
NO20053712L
NO20053712L NO20053712A NO20053712A NO20053712L NO 20053712 L NO20053712 L NO 20053712L NO 20053712 A NO20053712 A NO 20053712A NO 20053712 A NO20053712 A NO 20053712A NO 20053712 L NO20053712 L NO 20053712L
Authority
NO
Norway
Prior art keywords
sub
preparation
imidazole derivatives
substituted imidazole
intermediates used
Prior art date
Application number
NO20053712A
Other languages
English (en)
Other versions
NO330965B1 (no
Inventor
Paivi Juujarvi
Seppo Parhi
Jaana Karjalainen
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Publication of NO20053712L publication Critical patent/NO20053712L/no
Publication of NO330965B1 publication Critical patent/NO330965B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20053712A 2003-01-08 2005-08-01 Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt NO330965B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030026A FI116292B (fi) 2003-01-08 2003-01-08 Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
PCT/FI2004/000004 WO2004063168A1 (en) 2003-01-08 2004-01-08 Process for preparing substituted imidazole derivatives and intermediates used in the process

Publications (2)

Publication Number Publication Date
NO20053712L true NO20053712L (no) 2005-08-01
NO330965B1 NO330965B1 (no) 2011-08-29

Family

ID=8565279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053712A NO330965B1 (no) 2003-01-08 2005-08-01 Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt

Country Status (21)

Country Link
US (1) US7223871B2 (no)
EP (1) EP1581504B1 (no)
JP (1) JP4592680B2 (no)
KR (1) KR101079065B1 (no)
CN (1) CN100339368C (no)
AT (1) ATE425972T1 (no)
AU (1) AU2004203941B2 (no)
BR (1) BRPI0406676A (no)
CA (1) CA2511969C (no)
DE (1) DE602004020050D1 (no)
DK (1) DK1581504T3 (no)
ES (1) ES2322463T3 (no)
FI (1) FI116292B (no)
IL (1) IL168452A (no)
MX (1) MXPA05007217A (no)
NO (1) NO330965B1 (no)
NZ (1) NZ539831A (no)
PL (1) PL213564B1 (no)
PT (1) PT1581504E (no)
RU (1) RU2329253C2 (no)
WO (1) WO2004063168A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2456749B1 (en) 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Indane derivatives for use as intermediates
WO2011014613A2 (en) * 2009-07-31 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of fipamezole
EP2502917A1 (en) * 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
CN1372551A (zh) 1999-09-06 2002-10-02 株式会社Lgci 制备1－取代的5－羟甲基咪唑的方法
US7091232B2 (en) * 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Also Published As

Publication number Publication date
CN1723202A (zh) 2006-01-18
MXPA05007217A (es) 2005-09-12
NO330965B1 (no) 2011-08-29
CA2511969C (en) 2011-10-11
US7223871B2 (en) 2007-05-29
FI116292B (fi) 2005-10-31
ATE425972T1 (de) 2009-04-15
NZ539831A (en) 2007-11-30
KR20050091065A (ko) 2005-09-14
EP1581504B1 (en) 2009-03-18
FI20030026A0 (fi) 2003-01-08
AU2004203941A1 (en) 2004-07-29
EP1581504A1 (en) 2005-10-05
PL378179A1 (pl) 2006-03-06
JP2006515349A (ja) 2006-05-25
FI20030026L (fi) 2004-07-09
KR101079065B1 (ko) 2011-11-02
WO2004063168A1 (en) 2004-07-29
CA2511969A1 (en) 2004-07-29
PT1581504E (pt) 2009-05-26
DE602004020050D1 (de) 2009-04-30
IL168452A (en) 2009-07-20
CN100339368C (zh) 2007-09-26
PL213564B1 (pl) 2013-03-29
US20060025465A1 (en) 2006-02-02
ES2322463T3 (es) 2009-06-22
RU2005125044A (ru) 2006-01-20
BRPI0406676A (pt) 2005-12-20
JP4592680B2 (ja) 2010-12-01
RU2329253C2 (ru) 2008-07-20
AU2004203941B2 (en) 2009-08-06
DK1581504T3 (da) 2009-06-29

Similar Documents

Publication Publication Date Title
PT2428519E (pt) Processo para preparação de 17-o-vinil-triflatos como intermediários
WO2007041167A3 (en) Process for production of delta-9-tetrahydrocannabinol
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
MEP18708A (en) Process for the production of beraprost and its salts
MY139404A (en) Preparation process of some halogeno-substituted monosulfides and their hydroxymonosulfide or isothiouronium bromide equivalents as intermediates
WO2005058812A3 (en) Prostaglandin synthesis
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
NO20010265D0 (no) 3-(1-hydroksy-pentyliden)-5-nitro-3H-benzofuran-2-on, fremgangsmåte for fremstilling og anvendelse derav
EP1439165A4 (en) INHIBITOR OF THE BIOSYNTHESIS OF ABSIC ACID
NO20032314L (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
MEP1708A (xx) Postupak proizvodnje thip-a
MXPA03011647A (es) Procedimiento de resolucion para el acido ( r ) - (-) - 2-hidroxi - 2- (2 - clorofenil) acetico.
EA200700767A1 (ru) Способ получения пиразолов
IS6636A (is) Hringlaga ketonar og notkun þeirra í smíði amínósýra
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
DK1631533T3 (da) Hidtil ukendt fremgangsmåde til stereoselektiv reduktion af beta-ketoestre
DE60114889D1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
DE50107619D1 (de) Verfahren zur herstellung von 4-brom-anilin-derivaten
JO3022B1 (ar) طريقة لانتاج 2'-دياوكسي-5-ازاسيتيدين (ديسيتابين)
KR20030033819A (ko) 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체
NO20055925L (no) Ny fremgangsmate for fremstilling av melagatran

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees